Programme
Thursday, October 17th, 2024
| 06:20 – 06:30 pm |
Welcome – Georg Schett |
| 06:30 – 07:00 pm |
Bamberg, the city of the birth of modern medicine – Bernhard Manger |
| 07:00 pm |
Dinner at Welcome Kongresshotel Bamberg |
Friday, October 18th, 2024
| 08:00 – 08:10 am |
Welcome and Opening Remarks |
|
Session 1: RA: From genetics to new pathways
|
| 08:10 – 08:40 am |
Genetic and proteomic pathways in RA – Saedis Saevarsdottir |
| 08:40 – 09:10 am |
Multi-omics studies on immune mediated diseases – Kazuhiko Yamamoto |
| 09:10 – 09:40 am |
Specificities and functional features of ACPAs – Caroline Groenwall |
| 09:40 – 10:00 am |
Discussion |
| 10:00 – 10:30 am |
Break |
|
Session 2: RA: Interfering in Pre-RA – on the way to prevent onset of RA
|
| 10:30 – 11:00 am |
RA interception: lessons from the APIPPRA trial – Andrew Cope |
| 11:00 – 11:30 am |
Lessons from Hydroxychloroquine in Stop-RA and Implications for Next Generation Prevention Strategies – Michael Holers |
| 11:30 – 12:00 pm |
The role of methotrexate in reducing subclinical inflammation and inhibiting onset of RA – Annette Van der Helm |
| 12:00 – 12:30 pm |
Abatacept reducing MRI inflammation and inhibiting onset of RA – Georg Schett |
| 12:30 – 12:50 pm |
Discussion |
| 12:50 – 02:00 pm |
Lunch |
|
Session 3: Tolerizing therapies in RA
|
| 02:00 – 02:30 pm |
Tolerizing immunotherapy with peptide-containing liposomes – Ranjeny Thomas |
| 02:30 – 03:00 pm |
How to develop tolerance-inducing therapies in RA? – Bruno Raposo |
| 03:00 – 03:30 pm |
Immune reset in RA, including tolerance induction by dendritic cells – John Isaacs |
| 03:30 – 03:50 pm |
Discussion |
| 03:50 – 04:20 pm |
Break |
|
Session 4: Stratifying RA subset by tissue analysis
|
| 04:20 – 04:50 pm |
From synovial pathology to treatment response – Costantino Pitzalis |
| 04:50 – 05:20 pm |
From lymphcyte signatures to treatment response – Satoshi Kubo |
| 05:20 – 05:50 pm |
Characterization of molecular remission states in RA – Stefano Alivernini |
| 05:50 – 08:10 pm |
Discussion |
| 07:30 – 10:00 pm |
Dinner |
Saturday, October 19th, 2024
|
Session 5: Mucosal pathways triggering the onset of RA
|
| 08:00 – 08:30 am |
Lymphocyte repertoires and antigen specificities in rheumatoid arthritis – from the lung to the joint – Sara Turcinov |
| 08:30 – 09:00 am |
Mucosal-microbial interactions associated with the onset of RA – Kristine A. Kuhn |
| 09:00 – 09:30 am |
Epithelial cell necroptosis in development of arthritis – Aline Bozec |
| 09:30 – 10:00 am |
Cross-reactive bacterial and viral immune responses in development of RA – William Robinson |
| 10:00 – 10:20 am |
Discussion |
| 10:20 – 10:45 am |
Break |
|
Session 6: B cell function in RA
|
| 10:45 – 11:15 am |
New insights into „Autoantigen-B cells“ in diagnosis and treatment of rheumatoid arthritis – Fanlei Hu |
| 11:15 – 11:45 am |
Targeting B cells in rheumatoid arthritis – Zhu Chen |
| 11:45 – 12:15 pm |
B cell contributions to bone erosion in RA – Jennifer Anolik |
| 12:15 – 12:35 pm |
Discussion |
| 12:35 – 01:30 pm |
Lunch |
|
Section 7: New insights in RA
|
| 01:30 – 02:00 pm |
New insights into the mode of action of glucocorticoids – Gerhard Krönke |
| 02:00 – 02:30 pm |
New insights into autoantibodies in RA – Rene Toes |
| 02:30 – 03:00 pm |
New insights into imaging of RA – Maria-Antonietta D’Agostino |
| 03:00 – 03:20 pm |
Discussion |
| 03:20 – 03:45 pm |
Break |
|
Section 8: New treatment concepts in RA
|
| 03:45 – 04:15 pm |
Possibilities to treat autoimmune disease by engineered cells – Dimitrios Mougiakakos |
| 04:15 – 04:45 pm |
Targeting fibroblasts in RA – Adam Croft |
| 04:45 – 05:15 pm |
T cell engagers in breaking treatment resistance in RA – Ricardo Grieshaber-Bouyer |
| 05:15 – 05:35 pm |
Discussion |
| 05:35 – 05:45 pm |
Wrap up and Closing |
